Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss.

Poindron V, Berat R, Knapp AM, Toti F, Zobairi F, Korganow AS, Chenard MP, Gounou C, Pasquali JL, Brisson A, Martin T.

J Thromb Haemost. 2011 Oct;9(10):1937-47. doi: 10.1111/j.1538-7836.2011.04475.x.

2.

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

Rand JH, Wu XX, Andree HA, Lockwood CJ, Guller S, Scher J, Harpel PC.

N Engl J Med. 1997 Jul 17;337(3):154-60. Erratum in: N Engl J Med 1997 Oct 30;337(18):1327.

3.

Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms.

Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, Palomo I, Harris EN, Meroni PL.

Semin Thromb Hemost. 2008 Apr;34(3):236-50. doi: 10.1055/s-0028-1082267. Review.

PMID:
18720303
5.

Tracing the molecular pathogenesis of antiphospholipid syndrome.

Weiler H.

J Clin Invest. 2008 Oct;118(10):3276-8. doi: 10.1172/JCI37243.

6.

Antiphospholipid antibodies in obstetrics: new complexities and sites of action.

Caruso A, De Carolis S, Di Simone N.

Hum Reprod Update. 1999 May-Jun;5(3):267-76. Review.

7.

The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis.

Rand JH, Wu XX, Quinn AS, Taatjes DJ.

Lupus. 2010 Apr;19(4):460-9. doi: 10.1177/0961203310361485. Review.

PMID:
20353989
8.

The pathogenic role of annexin-V in the antiphospholipid syndrome.

Rand JH.

Curr Rheumatol Rep. 2000 Jun;2(3):246-51. Review.

PMID:
11123066
9.

Antiphospholipid antibodies as cause of pregnancy loss.

Meroni PL, di Simone N, Testoni C, D'Asta M, Acaia B, Caruso A.

Lupus. 2004;13(9):649-52. Review.

PMID:
15485095
10.

Antiphospholipid antibodies and pregnancy.

Galli M, Barbui T.

Best Pract Res Clin Haematol. 2003 Jun;16(2):211-25. Review.

PMID:
12763488
11.

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.

Girardi G, Redecha P, Salmon JE.

Nat Med. 2004 Nov;10(11):1222-6. Epub 2004 Oct 17.

PMID:
15489858
12.

Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes.

Van Horn JT, Craven C, Ward K, Branch DW, Silver RM.

Placenta. 2004 Aug;25(7):642-8.

PMID:
15193871
13.

Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.

Rand JH, Wu XX, Guller S, Gil J, Guha A, Scher J, Lockwood CJ.

Am J Obstet Gynecol. 1994 Dec;171(6):1566-72.

PMID:
7802069
14.
15.

The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients.

Salmon JE, Girardi G, Lockshin MD.

Nat Clin Pract Rheumatol. 2007 Mar;3(3):140-7; quiz 1 p following 187. Review.

PMID:
17334336
16.

Atypical onset of antiphospholipid syndrome in pregnancy: a case report.

Riviello C, Ammannati F, Lamassa M, Mariotti F, Mennonna P, Parretti E, Tondi F, Mello G.

Thromb Res. 2005;115(5):405-8. Epub 2005 Jan 16.

PMID:
15733974
17.

Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.

Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ.

Am J Obstet Gynecol. 1997 Oct;177(4):918-23.

PMID:
9369845
18.

Resistance to annexin A5 anticoagulant activity: a thrombogenic mechanism for the antiphospholipid syndrome.

Rand JH, Wu XX, Quinn AS, Taatjes DJ.

Lupus. 2008 Oct;17(10):922-30. doi: 10.1177/0961203308095029. Review.

PMID:
18827057
19.

Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?

Alijotas-Reig J, Vilardell-Tarres M.

Obstet Gynecol Surv. 2010 Jan;65(1):39-45. doi: 10.1097/OGX.0b013e3181c97809. Review.

PMID:
20040128
20.

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.

Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, Bajema IM.

J Pathol. 2011 Dec;225(4):502-11. doi: 10.1002/path.2893. Epub 2011 Jun 20.

PMID:
21688269
Items per page

Supplemental Content

Write to the Help Desk